Cargando…

Efficacy of nitazoxanide to treat natural Giardia infections in dogs

BACKGROUND: Giardia parasites cause gastrointestinal disease in humans, dogs, and many other animals worldwide. The treatment of dogs for giardiasis requires further investigation to ascertain levels of drug efficacy and the possibility of adverse side effects. Nitazoxanide (NTZ) has shown good clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Moron-Soto, Mario, Gutierrez, Lilia, Sumano, Héctor, Tapia, Graciela, Alcala-Canto, Yazmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286866/
https://www.ncbi.nlm.nih.gov/pubmed/28143543
http://dx.doi.org/10.1186/s13071-017-1998-7
_version_ 1782504080994729984
author Moron-Soto, Mario
Gutierrez, Lilia
Sumano, Héctor
Tapia, Graciela
Alcala-Canto, Yazmin
author_facet Moron-Soto, Mario
Gutierrez, Lilia
Sumano, Héctor
Tapia, Graciela
Alcala-Canto, Yazmin
author_sort Moron-Soto, Mario
collection PubMed
description BACKGROUND: Giardia parasites cause gastrointestinal disease in humans, dogs, and many other animals worldwide. The treatment of dogs for giardiasis requires further investigation to ascertain levels of drug efficacy and the possibility of adverse side effects. Nitazoxanide (NTZ) has shown good clinical anti-Giardia activity in humans, yet it has not been evaluated for the treatment of giardiasis in dogs. METHODS: Thirty-five dogs, naturally infected with Giardia were divided into five groups (n = 7): dogs in group NTZ1, NTZ2, and NTZ3 were treated with a single oral dose of 37.5 mg/kg, 75 mg/kg, and 150 mg/kg, respectively, of NTZ on days 0 and 14. The fourth group was treated with a commercially available regimen that includes a combination of pyrantel, praziquantel, and febantel (FEB) administered orally for three consecutive days. Additionally, an untreated control group was established. Giardia cysts from the stool of each dog were quantified on days -3, 0, 5, 7, 9, 11, 14, 18, 25, and 28. Biochemical parameters were evaluated in all dogs, before the first treatment and after concluding the experiment. RESULTS: Shedding of Giardia cysts was reduced in all treated groups when compared to untreated controls (P < 0.01). However, NTZ2, NTZ3, and FEB had a lower risk during the study. Furthermore, NTZ was also effective against another protozoan, Cryptosporidium spp. at doses of 75 mg/kg and 150 mg/kg, in contrast to the combination of febantel + pyrantel + praziquantel. Biochemical parameters of treated animals, namely, aspartate transaminase and alanine transaminase enzymes, remained within physiological ranges. CONCLUSIONS: Based on these results, the implementation of NTZ as a treatment for giardiasis in dogs is proposed. The administration of a single dose is an important advantage of NTZ because it reduces workload, particularly in animals placed in shelters and kennels, where handling of large numbers of animals is required, and personnel is frequently scarce.
format Online
Article
Text
id pubmed-5286866
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52868662017-02-06 Efficacy of nitazoxanide to treat natural Giardia infections in dogs Moron-Soto, Mario Gutierrez, Lilia Sumano, Héctor Tapia, Graciela Alcala-Canto, Yazmin Parasit Vectors Research BACKGROUND: Giardia parasites cause gastrointestinal disease in humans, dogs, and many other animals worldwide. The treatment of dogs for giardiasis requires further investigation to ascertain levels of drug efficacy and the possibility of adverse side effects. Nitazoxanide (NTZ) has shown good clinical anti-Giardia activity in humans, yet it has not been evaluated for the treatment of giardiasis in dogs. METHODS: Thirty-five dogs, naturally infected with Giardia were divided into five groups (n = 7): dogs in group NTZ1, NTZ2, and NTZ3 were treated with a single oral dose of 37.5 mg/kg, 75 mg/kg, and 150 mg/kg, respectively, of NTZ on days 0 and 14. The fourth group was treated with a commercially available regimen that includes a combination of pyrantel, praziquantel, and febantel (FEB) administered orally for three consecutive days. Additionally, an untreated control group was established. Giardia cysts from the stool of each dog were quantified on days -3, 0, 5, 7, 9, 11, 14, 18, 25, and 28. Biochemical parameters were evaluated in all dogs, before the first treatment and after concluding the experiment. RESULTS: Shedding of Giardia cysts was reduced in all treated groups when compared to untreated controls (P < 0.01). However, NTZ2, NTZ3, and FEB had a lower risk during the study. Furthermore, NTZ was also effective against another protozoan, Cryptosporidium spp. at doses of 75 mg/kg and 150 mg/kg, in contrast to the combination of febantel + pyrantel + praziquantel. Biochemical parameters of treated animals, namely, aspartate transaminase and alanine transaminase enzymes, remained within physiological ranges. CONCLUSIONS: Based on these results, the implementation of NTZ as a treatment for giardiasis in dogs is proposed. The administration of a single dose is an important advantage of NTZ because it reduces workload, particularly in animals placed in shelters and kennels, where handling of large numbers of animals is required, and personnel is frequently scarce. BioMed Central 2017-01-31 /pmc/articles/PMC5286866/ /pubmed/28143543 http://dx.doi.org/10.1186/s13071-017-1998-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Moron-Soto, Mario
Gutierrez, Lilia
Sumano, Héctor
Tapia, Graciela
Alcala-Canto, Yazmin
Efficacy of nitazoxanide to treat natural Giardia infections in dogs
title Efficacy of nitazoxanide to treat natural Giardia infections in dogs
title_full Efficacy of nitazoxanide to treat natural Giardia infections in dogs
title_fullStr Efficacy of nitazoxanide to treat natural Giardia infections in dogs
title_full_unstemmed Efficacy of nitazoxanide to treat natural Giardia infections in dogs
title_short Efficacy of nitazoxanide to treat natural Giardia infections in dogs
title_sort efficacy of nitazoxanide to treat natural giardia infections in dogs
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286866/
https://www.ncbi.nlm.nih.gov/pubmed/28143543
http://dx.doi.org/10.1186/s13071-017-1998-7
work_keys_str_mv AT moronsotomario efficacyofnitazoxanidetotreatnaturalgiardiainfectionsindogs
AT gutierrezlilia efficacyofnitazoxanidetotreatnaturalgiardiainfectionsindogs
AT sumanohector efficacyofnitazoxanidetotreatnaturalgiardiainfectionsindogs
AT tapiagraciela efficacyofnitazoxanidetotreatnaturalgiardiainfectionsindogs
AT alcalacantoyazmin efficacyofnitazoxanidetotreatnaturalgiardiainfectionsindogs